GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Anhui Huaren Health Pharmaceutical Co Ltd (SZSE:301408) » Definitions » 3-Year EBITDA Growth Rate

Anhui Huaren Health Pharmaceutical Co (SZSE:301408) 3-Year EBITDA Growth Rate : 34.30% (As of Mar. 2024)


View and export this data going back to 2023. Start your Free Trial

What is Anhui Huaren Health Pharmaceutical Co 3-Year EBITDA Growth Rate?

Anhui Huaren Health Pharmaceutical Co's EBITDA per Share for the three months ended in Mar. 2024 was ¥0.18.

During the past 12 months, Anhui Huaren Health Pharmaceutical Co's average EBITDA Per Share Growth Rate was -83.90% per year. During the past 3 years, the average EBITDA Per Share Growth Rate was 34.30% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was 45.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 6 years, the highest 3-Year average EBITDA Per Share Growth Rate of Anhui Huaren Health Pharmaceutical Co was 62.00% per year. The lowest was 34.30% per year. And the median was 59.00% per year.


Competitive Comparison of Anhui Huaren Health Pharmaceutical Co's 3-Year EBITDA Growth Rate

For the Pharmaceutical Retailers subindustry, Anhui Huaren Health Pharmaceutical Co's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Anhui Huaren Health Pharmaceutical Co's 3-Year EBITDA Growth Rate Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Anhui Huaren Health Pharmaceutical Co's 3-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Anhui Huaren Health Pharmaceutical Co's 3-Year EBITDA Growth Rate falls into.



Anhui Huaren Health Pharmaceutical Co 3-Year EBITDA Growth Rate Calculation

This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.


Anhui Huaren Health Pharmaceutical Co  (SZSE:301408) 3-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.


Anhui Huaren Health Pharmaceutical Co 3-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of Anhui Huaren Health Pharmaceutical Co's 3-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


Anhui Huaren Health Pharmaceutical Co (SZSE:301408) Business Description

Traded in Other Exchanges
N/A
Address
Shanghai Road, Chinese Health Building, No.18, Baohe Industrial Zone, Anhui Province, Hefei, CHN, 230051
Anhui Huaren Health Pharmaceutical Co Ltd focuses on the pharmaceutical retail industry and forms a retail chain, retail centralized procurement, retail service, and retail e-commerce system.
Executives
Yin Jun Directors, executives

Anhui Huaren Health Pharmaceutical Co (SZSE:301408) Headlines

No Headlines